• Jobs
  • Startups
  • Hire
LoginSign up

Liberate Bio

Liberate Bio has 3 open roles. Funding stage: Seed. Last round: $31M, Oct 15, 2025.

Open roles

  • Liberate Bio logo
    Biologists

    Liberate Bio

    • Boston, MA
    • On-site
    liberatebio.com
  • Liberate Bio logo
    Administrative

    Liberate Bio

    • Boston, MA
    • On-site
    liberatebio.com
  • Liberate Bio logo
    Chemists

    Liberate Bio

    • Boston, MA
    • On-site
    liberatebio.com

About

Liberate Bio logo

Liberate Bio

At Liberate Bio, we are not just improving genetic medicine—we are rewriting the rules of drug delivery.

Today, the biggest bottleneck in genetic medicine isn’t the power of mRNA, CRISPR, or gene therapy—it’s that we can’t get these medicines anywhere but the liver. Our RAPTOR™ platform is the first AI-driven system that makes extrahepatic genetic medicine scalable. Unlike the slow, inefficient trial-and-error process that dominates biotech, we directly test hundreds of novel lipid nanoparticles (LNPs) in non-human primates (NHPs) at 100 times lower cost, generating real-world, human-relevant data.

Private companySeedTiny team, big raise
Founded2022
HQBoston, United States
Unlock human wisdom
ThesisTermsPrivacy
Size12 employees
IndustryBiotechnology Research
Funding
  • Seed · $31M · Oct 15, 2025
Investors
Khosla Ventures

Claim liberatebio.com

Work at liberatebio.com? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.